132 related articles for article (PubMed ID: 38670244)
1. Evaluation of the inhibitory effects of antigout drugs on human carboxylesterases in vitro.
Liang JH; Yi XL; Gong JM; Du Z
Toxicol In Vitro; 2024 Jun; 98():105833. PubMed ID: 38670244
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from
Fu Q; Yang K; Hu RX; Du Z; Hu CM; Zhang X
Xenobiotica; 2019 Nov; 49(11):1260-1268. PubMed ID: 30486721
[TBL] [Abstract][Full Text] [Related]
3. Hydroxylated polychlorinated biphenyls (OH-PCBs) exert strong inhibitory effects towards human carboxylesterases (CESs).
Sun HZ; Qin GQ; Wang FG; Bai Y; Zhang Z; Fang ZZ
Sci Total Environ; 2020 Nov; 745():141140. PubMed ID: 32736114
[TBL] [Abstract][Full Text] [Related]
4. Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases.
Liu YZ; Pan LH; Bai Y; Yang K; Dong PP; Fang ZZ
Environ Pollut; 2020 Aug; 263(Pt A):114463. PubMed ID: 32283456
[TBL] [Abstract][Full Text] [Related]
5. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the inhibitory effects of pyrethroids against human carboxylesterases.
Lei W; Wang DD; Dou TY; Hou J; Feng L; Yin H; Luo Q; Sun J; Ge GB; Yang L
Toxicol Appl Pharmacol; 2017 Apr; 321():48-56. PubMed ID: 28242322
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of phthalate esters (PAEs) and phthalate monoesters towards human carboxylesterases (CESs).
Gong JM; Yi XL; Liang JH; Liu ZZ; Du Z
Toxicol Appl Pharmacol; 2024 Jan; 482():116785. PubMed ID: 38070751
[TBL] [Abstract][Full Text] [Related]
9. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues.
Hammid A; Fallon JK; Lassila T; Vieiro P; Balla A; Gonzalez F; Urtti A; Smith PC; Tolonen A; Honkakoski P
Drug Metab Dispos; 2022 Dec; 50(12):1483-1492. PubMed ID: 36195336
[TBL] [Abstract][Full Text] [Related]
10. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
11. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B
J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648
[TBL] [Abstract][Full Text] [Related]
12. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
[TBL] [Abstract][Full Text] [Related]
13. Carboxylesterase Inhibitors: An Update.
Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
[TBL] [Abstract][Full Text] [Related]
14. Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase.
Yasuda K; Watanabe K; Fukami T; Nakashima S; Ikushiro SI; Nakajima M; Sakaki T
Drug Metab Pharmacokinet; 2021 Aug; 39():100397. PubMed ID: 34171773
[TBL] [Abstract][Full Text] [Related]
15. The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.
Shen Y; Eades W; Liu W; Yan B
Drug Metab Dispos; 2022 Sep; 50(9):1151-1160. PubMed ID: 35790245
[TBL] [Abstract][Full Text] [Related]
16. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
[TBL] [Abstract][Full Text] [Related]
17. Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?
Xu J; Qiu JC; Ji X; Guo HL; Wang X; Zhang B; Wang T; Chen F
Curr Drug Metab; 2019; 20(2):130-137. PubMed ID: 29600756
[TBL] [Abstract][Full Text] [Related]
18. Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.
Gabriele M; Puccini P; Gervasi PG; Longo V
Life Sci; 2021 Jul; 277():119486. PubMed ID: 33864822
[TBL] [Abstract][Full Text] [Related]
19. Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.
Xiao D; Shi D; Yang D; Barthel B; Koch TH; Yan B
Biochem Pharmacol; 2013 Feb; 85(3):439-47. PubMed ID: 23228697
[TBL] [Abstract][Full Text] [Related]
20. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase.
Shimizu M; Fukami T; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
